TYRA
Tyra Biosciences, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +30.0% ·
share flow +30.0% ·
net new positions +20.0%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | +2 | 26.25M | $838.89M | +9 | −7 |
| Q1 2026 | 71 | +10 | 23.52M | $900.04M | +12 | −2 |
| Q4 2025 | 61 | -1 | 13.06M | $343.28M | +1 | −2 |
| Q3 2025 | 17 | 0 | 6.63M | $92.78M | — | — |
| Q2 2025 | 14 | +2 | 5.95M | $56.99M | +2 | — |
| Q1 2025 | 9 | -1 | 2.08M | $19.36M | — | −1 |
| Q4 2024 | 10 | +1 | 1.73M | $24.09M | +2 | −1 |
| Q3 2024 | 8 | +5 | 939.26K | $22.08M | +5 | — |
| Q2 2024 | 3 | — | 674.98K | $10.79M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 523.19K | +0.1% | $12.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 523.19K | +0.1% | $12.30M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Adage Capital Partners ✦ | 200.00K | New | $4.70M | 0.0% | New | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 90.83K | -22.4% | $2.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 90.83K | -22.4% | $2.14M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Two Sigma Investments ✦ | 39.18K | +11.1% | $921,028 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 32.00K | New | $752,391 | 0.0% | New | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 23.95K | New | $563,112 | 0.0% | New | 1 | SEC ↗ |
| 9 | Marshall Wace ✦ | 19.61K | New | $461,125 | 0.0% | New | 1 | SEC ↗ |
| 10 | Millennium Management ✦ | 10.50K | New | $246,949 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Adage Capital Partners | $4.70M | 0.0% |
| D. E. Shaw & Co. | $752,391 | 0.0% |
| Citadel Advisors | $563,112 | 0.0% |
| Marshall Wace | $461,125 | 0.0% |
| Millennium Management | $246,949 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 163 holders, 65.87M shares, $2.48B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.